1Basso K, Dalla-Favera R.BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis[J].Adv Immunol, 2010, 105(10): 193-210.
2Schlegel U, Jürgens A, Pels H.Primary central nervous system lymphomas (PCNSL): MRI response criteria revised[J].Neurology, 2006, 66(8): 1287.
3Thompsett AR, Ellison DW, Stevenson FK, et al.V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity[J].Blood, 1999, 94(5): 1738-1746.
4Deckert M, Brunn A, Montesinos-Rongen M, et al.Primary lymphoma of the central nervous system: a diagnostic challenge[J].Hematol Oncol, 2014, 32(2): 57-67.
5Korfel A, Schlegel U.Diagnosis and treatment of primary CNS lymphoma[J].Nat Rev Neurol, 2013, 9(6): 317-327.
7Roth P, Martus P, Kiewe P, et al.Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1trial[J].Neurology, 2012, 79(9): 890-896.
8Holdhoff M, Ambady P, Abdelaziz A, et al.High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma[J].Neurology, 2014, 83(3): 235-239.
9Bierman PJ.Surgery for primary central nervous system lymphoma: is it time for reevaluation[J].Oncology (Williston Park), 2014, 28(7): 632-637.
10Prica A, Chan K, Cheung M.Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a cost-effectiveness analysis[J].Neuro Oncol, 2014, 16(10): 1384-1391.
